Chronic Statin Administration May Attenuate Early Anthracycline-Associated Declines in Left Ventricular Ejection Function
Conclusions These data highlight the finding that individuals receiving statin therapy for prevention of cardiovascular disease may experience less deterioration in LVEF with early receipt of Anth-bC than individuals not receiving statins. Further studies with large numbers of participants are warranted to determine if statins protect against LVEF decline in patients receiving Anth-bC.
Source: Canadian Journal of Cardiology - Category: Cardiology Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Cardiology | Cardiovascular | Chemotherapy | Cholesterol | Chronic Leukemia | Diabetes | Diabetes Mellitus | Endocrinology | Heart | Heart Failure | Hypertension | Legislation | Leukemia | Lymphoma | Middle East Health | MRI Scan | Statin Therapy | Study | Women